Events

This webinar will discuss the many advantages of moving your early phase trials to Australia including:

• Almost 50% lower cost,
• Attractive regulatory environment for rapid trial approvals
• Internationally regarded for quality science
• World-leading investigators and KOLs
• Phase 1 units and most sites open during COVID-19 crisis

Life Sciences Queensland is partnering with Logan Startup Hub to bring you this exciting virtual event where Life Sciences Companies present their innovative business ventures.

This event will help you experience and understand the development of startups and business ventures in the Life Science field in order to inspire, stimulate thought and highlight innovation.

The BIO International Convention is better than ever! From an enhanced partnering experience, to expanded registration benefits, insightful sessions, and unforgettable networking opportunities, BIO 2020 helps you dream big and tackle daunting industry challenges.

The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. What‘s unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.

For more than 50 years, DIA has provided the world’s largest global, neutral stage for life science professionals to come together and address healthcare challenges. Driven by purpose and focused on the future of health, the stakeholders who gather at our Global Annual Meeting advance science and technology for public health impact – today, and for generations to come.

Johnson & Johnson Innovation’s World Without Disease Accelerator (WWDA) is driving the paradigm shift from disease care to health care incorporating innovative approaches to prevention, interception, early intervention and cure.

The Australian Johnson & Johnson Innovation Partnering Offices invite you to attend this virtual briefing and partnering update detailing opportunities for collaboration and investment with WWDA as these apply to Coeliac Disease, Microbiome Institute and the Healthy Baby Initiative.

LSQ through the LS Catalyst program is proud to support the delivery of the BRIGHT Ideate program for Queensland digital health companies. The BRIGHT Ideate in digital health program will be delivered by ANDHealth and Planet Innovation which provides a proven framework of learning along with tailored advice and thinking models to digital health companies in order to reach successful commercialisation. The program is suitable for all digital health innovators, regardless of the stage of development.

The current COVID19 situation has driven innovation within the business community. With limitations to existing supply chains, many local manufactures are being forced to think differently about their existing business operations.

Responding to current market impacts may require an open mindset, strong leadership, a culture of innovation and the adoption of new emerging technologies. The content of this event will assist you identify areas of opportunity within your business and give you some tools to help grow those opportunities in these challenging times.

Europe CEO is an invitation-only, off-the-record forum that brings together industry leaders to network and share insights on the challenges and opportunities impacting the international biopharma community. The one-day event takes place just before BIO-Europe, and includes a number of panel discussions, fireside chats, and plenty of networking opportunities during breakfast, lunch and the closing receptions. The event is invitation only. To request your invitation please click on the More Info Here link below. LSQ members can also contact us to receive a large discount following invitation.

The APSIM Initiative is conducting a 1-day update symposium followed by a 2-day advanced training event in March 2020 in Brisbane.

The program is set to highlight key APSIM developments and related scientific success stories. The Symposium will also provide an update on the latest technology and innovations including the new work in APSIM Next Generation.